Skip to main content
Top
Published in: BMC Geriatrics 1/2023

Open Access 01-12-2023 | Wart | Correction

Correction: Reduction of care-relevant risks to older patients during and after acute hospital care (ReduRisk) – study protocol of a cluster randomized efficacy trial in a stepped wedge design

Authors: Anne Göhner, Elena Dreher, Felix Kentischer, Christoph Maurer, Erik Farin-Glattacker, Rieka von der Warth, Boris A. Brühmann, Andy Maun, Vitalii Minin, Claudia Salm, Alexander Ritzi, Gwendolyn Engelhardt, Mario Sofroniou, Sebastian Voigt-Radloff

Published in: BMC Geriatrics | Issue 1/2023

Login to get access

Excerpt

Correction: BMC Geriatrics 22, 754 (2022)
Literature
Metadata
Title
Correction: Reduction of care-relevant risks to older patients during and after acute hospital care (ReduRisk) – study protocol of a cluster randomized efficacy trial in a stepped wedge design
Authors
Anne Göhner
Elena Dreher
Felix Kentischer
Christoph Maurer
Erik Farin-Glattacker
Rieka von der Warth
Boris A. Brühmann
Andy Maun
Vitalii Minin
Claudia Salm
Alexander Ritzi
Gwendolyn Engelhardt
Mario Sofroniou
Sebastian Voigt-Radloff
Publication date
01-12-2023
Publisher
BioMed Central
Keyword
Wart
Published in
BMC Geriatrics / Issue 1/2023
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-022-03580-9

Other articles of this Issue 1/2023

BMC Geriatrics 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine